Karl Schmid is a W3 Professor of Crop Plant Biodiversity and Breeding Informatics at the University of Hohenheim's Institute of Plant Breeding, Seed Science and Population Genetics within the College of Agricultural Sciences. His research integrates evolutionary genetics, population genomics, and machine learning to address agricultural challenges. Ph.D. in Biology, University of Munich (1996) Postdoctoral Research, Cornell University (1997-1999) Emmy-Noether Research Group, Max Planck Institute of Chemical Ecology (2000-2006) Group Leader, Leibniz Institute of Plant Genetics (2006-2008) Professor of Genetics, Swedish Agricultural University (2008) His research focuses on crop biodiversity conservation, evolutionary genetics of plant pathogens, and breeding informatics applications. Current work leverages deep learning for phenotyping (quinoa panicles, barley genomics) and analyzes pathogen evolution (Exserohilum turcicum in maize). His team actively develops computational tools like GGoutlieR for geo-genetic pattern detection. Recent publications demonstrate strong trends in applying AI to agricultural genomics, particularly in quinoa improvement and pathogen surveillance. His group leads the EU H2020 INVITE project on molecular markers in plant variety protection and organizes international symposia like the 2024 Quinoa Symposium at Hohenheim. Head of Crop Biodiversity and Breeding Informatics Group Principal Investigator, EU H2020 INVITE project Organizer, International Quinoa Symposium 2024
Daan van Aalten is a Professor at Aarhus University, affiliated with the Department of Molecular Biology and Genetics - Neurobiology within the Faculty of Natural Sciences. His research focuses on protein O-GlcNAcylation, a critical posttranslational modification linked to intellectual disability (OGT-CDG). He leads studies using model systems (mESCs, Drosophila, mice) to dissect molecular mechanisms underlying OGT-CDG phenotypes. Notable contributions include defining OGT-CDG as a congenital disorder of glycosylation and identifying therapeutic targets. He has secured major grants, including a Novo Nordisk Foundation Laureate Grant (DKK 50M) and a Villum Investigator Grant (DKK 40M), supporting work on protein modifications and fungal pathogenesis. Key research areas include enzymology, structural biology, and neurobiology. His lab explores O-GlcNAc signaling dynamics, fungal cell wall synthesis, and genetic disorders. Recent studies highlight neurodevelopmental defects in mouse models and human stem cell systems. Collaborative projects with international teams advance drug discovery for fungal pathogens and intellectual disability syndromes. Publications span molecular mechanisms of OGT mutations, enzyme inhibitors, and structural biology. Awards include recognition for his transformative work in glycobiology and neurodevelopment. His lab actively engages in training scientists and welcomes inquiries about OGT-CDG studies via ogtcdg@au.dk.
Susanta Sarkar is a Research Professor at Arizona State University's School of Molecular Sciences, affiliated with the Tempe campus. His email is Susanta.Sarkar@asu.edu. He holds a NIH R01 GM145210 grant as the sole PI ($1.1 million), focusing on MMP1's role in collagen degradation. His research integrates biophysics, enzyme dynamics, and drug development to target matrix metalloproteases (MMPs) in diseases like cancer and neurodegeneration. He employs single-molecule techniques to study enzyme-substrate interactions, aiming to develop precision therapies with minimal side effects. Education : Ph.D. in Physics, University of Oregon (2006) M.S. in Physical Sciences, Indian Institute of Science (2000) Postdoctoral Associate, Cornell University (2008), NIH Research Fellow (2013) Research Interests : MMPs' role in human health, single-molecule biophysics, allosteric modulation, and drug screening for Parkinson’s/Alzheimer’s. His work bridges fundamental biology and translational medicine, funded by NIH. Publications : Recent work includes substrate-specific MMP dynamics, alpha-synuclein interactions, and biofilm inhibition. His 2020 Biophysical Journal study was cover-selected and F1000-recommended. Over 15 publications since 2016 address enzyme activity, thermodynamics, and imaging. Grants & Awards : NIH R01 GM145210 (2022-2026), $2.25 million in total funding. Recognized for innovative methodologies in single-molecule studies. Advising & Training : Supervised 54 trainees, including 3 PhDs securing >$1.5M in grants post-graduation. Emphasizes financial literacy alongside science, with students averaging $30K+ retirement savings. Service : Served on 12 NSF/NIH panels, reviewer for 20+ journals including Nature Communications and Biophysical Journal. Labs/Teams : Integrates personal finance education in group meetings to boost focus and career readiness. Lab focuses on MMPs, antimicrobial biopolymers, and fluorescent nanodiamond imaging.
Professor Vincent Archambault holds a full professorship at the University of Montreal's Faculty of Medicine, Department of Biochemistry and Molecular Medicine, and leads the Cell Cycle Regulation Research Unit at the Institute for Research in Immunology and Cancer (IRIC). His work focuses on molecular mechanisms regulating the cell division cycle, particularly in Drosophila models, with implications for cancer research. Education: B.Sc. in Biochemistry, Université de Montréal (1999) Ph.D. in Cell Cycle Studies, Rockefeller University (2004) Postdoctoral training at University of Cambridge (2004–2009) Research Interests: Cell cycle control, mitotic regulation, cancer biology, protein kinases (e.g., Polo, Greatwall), phosphatase networks (PP2A), and Drosophila model systems. His research identifies therapeutic targets for cancer by studying disruptions in cell cycle pathways. Key contributions include co-discovering Greatwall kinase and its role in mitotic regulation. Over 50 peer-reviewed articles highlight his work on nuclear reassembly, cytokinesis, and phosphatase-kinase interactions. Awards: Maud Menten New Principal Investigator Award (2009) GE Healthcare New Scientist Award (2015) Human Frontier Science Program Fellowship (2005–2009) Grants: Over 15 projects funded by CIHR, CRSNG, and others, totaling millions in research support. Labs/Teams: Leads the IRIC Cell Cycle Regulation Unit, collaborating with teams like Sylvain Meloche and Jean-Claude Labbé.
Alain Trouvé is a Professor at the Center for Mathematics and Their Applications (CMLA) within the Ecole Normale Supérieure de Cachan , France. His research focuses on Shape Spaces , Computational Anatomy , Imaging Processing , and Biological Imaging , with applications in medical and computational fields. He directs the Mathematics Department at ENS Cachan and contributes to neuroanatomical studies through diffeomorphometry techniques. Key roles include membership in the Conseil National des Universités (Section 26) and teaching responsibilities such as courses on Geometry and Shape Spaces and Probability Theory . His work spans from theoretical frameworks (e.g., Hamiltonian modeling of shape evolution) to practical applications like 3D cell imaging and white matter fiber analysis. Publications emphasize interdisciplinary methods, including diffeomorphic registration, varifold-based image analysis, and stochastic shape evolutions. Current projects explore multi-scale modeling of biological systems and AI-driven medical diagnostics. Key Research Themes: Diffeomorphic mappings, computational vision, and functional shape analysis. Teaching: Courses on geometric modeling and probability at undergraduate and graduate levels. Tools Developed: xIV-LDDMM Toolkit for multi-modal biomedical data analysis.
Lynn Cooley is the Dean of the Graduate School of Arts and Sciences and holds the C. N. H. Long Professorship in Genetics at Yale University. She is also Professor of Cell Biology and Molecular, Cellular, and Developmental Biology within the Yale School of Medicine. Her research focuses on cellular mechanisms of gamete development using Drosophila as a model system, particularly studying actin cytoskeleton organization in germline ring canals and somatic muscle development. Education: PhD in Genetics from University of Texas (1984), BA in Zoology from Connecticut College (1976) Her work investigates how intercellular bridges (ring canals) facilitate oocyte growth and maternal mRNA transport. Recent discoveries include novel muscle types in Drosophila ovaries and the role of the Kelch protein in actin dynamics. Cooley’s lab employs genetic, molecular, and imaging techniques to study these processes. Key awards include Fellow of the American Association for the Advancement of Science (2012) and Pew Scholar Award (1991). She has served on committees such as the Genetics Society of America Board and NIH Dev1 Study Section. Her research also explores tissue-specific codon redefinition and the antivirulence properties of antifreeze proteins. Collaborations include work with Andrew Hudson on Drosophila genetics and Joerg Bewersdorf on super-resolution microscopy.
Takashi Gojobori (born October 24, 1951) is a Japanese molecular biologist who serves as Vice-Director of the National Institute of Genetics (NIG) and Professor at the Center for Information Biology and DNA Data Bank of Japan (DDBJ) in Mishima, Japan. He also holds multiple visiting positions including Special Research Consultant at the National Institute of Advanced Industrial Science and Technology (AIST), Visiting Professor at Keio University, Tokyo University, and Tokyo Institute of Technology, and Visiting Research Director at RIKEN. His educational background includes a Ph.D. from Kyushu University (1979), followed by research positions at the University of Texas at Houston (1979-1983), Washington University in St. Louis (1985, 1986), and the Imperial Cancer Research Fund in London (1989). Professor Gojobori's research spans multiple areas of molecular and evolutionary biology. His work focuses on comparative genomics, molecular evolution, viral evolution, and bioinformatics. He has made significant contributions to understanding the rates of synonymous and non-synonymous substitutions, positive selection, horizontal gene transfer, and genome evolution. More recently, he has been investigating the evolution of the brain and central nervous system. His extensive publication record includes 389 peer-reviewed articles as of May 2012, reflecting his broad impact across multiple fields of biological research. His work shows a consistent focus on evolutionary mechanisms at the molecular level, with applications ranging from viral evolution to comparative genomics across diverse organisms including humans, plants, and model organisms like Hydra. Scientific Awards 2009: The Medal with Purple Ribbon from the government of Japan 2007: Academician Member of the Pontifical Academy of Sciences, Vatican 2006: Foreign Honorary Member of the American Academy of Arts and Sciences, USA 2005: Fellow of the American Association for the Advancement of Science (AAAS), USA 2005: Society Prize (Kihara Medal), The Genetic Society of Japan 2004: Society Prize (Motoo Kimura Medal), The Society of Evolutionary Studies, Japan 2004: The Gaetano Salvatore Gold Medal, Statione Zoologica, Anton Dohrn, Italy 1997: Science Award from Japan Science and Technology Corporation (JST), Japan 1995: Science Award from Hitoshi Kihara Memorial Foundation, Japan 1987: Promotion Award from Japanese Society of Genetics, Japan Professor Gojobori has served in numerous editorial capacities, including as Founding Editor of Genome Biology and Evolution, Executive Editor of GENE, and Associate Editor for several major journals. He has also held significant administrative roles including Program Director of the Council for Science and Technology Policy (CSTP) of the Japanese government and Science Officer of MEXT. His contributions to international genomic databases including DDBJ/GenBank/EMBL and the H-Invitational human gene database have been instrumental in advancing global genomics research. As Director of the Center for Information Biology and DNA Data Bank of Japan from 1994-2009, Professor Gojobori led important initiatives in biological data management and analysis. His work continues to influence the field through his leadership roles in international scientific organizations including the International Genetics Federation and CODATA/ICSU.
Kenichi Yokoyama serves as Associate Professor of Biochemistry (2019-Present), Associate Professor of Chemistry (2022-Present), and Associate Professor of Cell Biology (2022-Present) at Duke University. His primary appointment resides in the Department of Biochemistry within the Basic Science Departments, with secondary appointments in the Department of Chemistry under Trinity College of Arts & Sciences and the Department of Cell Biology. Dr. Yokoyama's research focuses on biosynthesis and mechanisms of action of naturally occurring bioactive molecules, particularly antifungals and antibiotics. His lab investigates biosynthetic enzymes and bacterial/fungal producers of bioactive metabolites to discover novel compounds with applications in research and medicine. His specific interests include free-radical mediated enzyme catalysis (metallo-enzymology), cofactor biosynthesis in humans and pathogenic bacteria, natural product biosynthesis and genome mining, and fungal cell wall biosynthesis with antifungal mode of action. His recent publications reveal a strong trend toward ribosomally synthesized and post-translationally modified peptide (RiPP) antibiotics like dynobactins and darobactins that target Gram-negative bacterial outer membranes. His work bridges organic chemistry, biochemistry, molecular biology, and spectroscopy with emphasis on functional and mechanistic characterization of enzymes, small molecule characterization, bacterial/fungal genetics, synthetic organic chemistry, and advanced spectroscopic techniques including NMR, EPR, and fluorescence microscopy. Scientific Awards: ACS Pfizer Award in Enzyme Chemistry (2019) - Recognizing fundamental research in enzyme chemistry by scientists under forty years of age Dr. Yokoyama maintains active grant funding from multiple NIH institutes (NIAID, NIGMS), NSF, and the American Heart Association, totaling over $10 million in current funding. His grants focus on molecular mycology, chitin synthesis inhibition, cell and molecular biology training, peptide antibiotic discovery, and advanced spectroscopy equipment. His lab also mentors students through various NIH-funded training programs including the Tri-Institutional Molecular Mycology and Pathogenesis Training Program and the Cell and Molecular Biology Training Program. The Yokoyama Lab operates at the intersection of enzymology and natural products research, maintaining strong collaborations across Duke's research ecosystem with particular emphasis on translating basic enzymatic discoveries into novel therapeutics for infectious diseases.
Dr. Laura Galazzo is a Lecturer at the Department of Chemistry and Applied Biosciences, ETH Zurich, affiliated with the Institute of Molecular Physical Sciences (IMPS). Her research focuses on biophysical chemistry and molecular dynamics, employing advanced spectroscopic techniques like Electron Paramagnetic Resonance (EPR) to study protein structure, phase transitions, and membrane transport mechanisms. She investigates topics such as liquid-liquid phase separation in proteins, ABC transporter function, and nitroxide radical dynamics in aqueous environments. Dr. Galazzo also contributes to methodological advancements in pulsed dipolar spectroscopy and neural network applications in spectroscopic data analysis. Her work bridges theoretical and experimental approaches, combining computational methods (e.g., ab initio molecular dynamics) with experimental techniques to address complex biological systems. Key areas of study include protein aggregation, conformational changes in large complexes, and the interplay between solvent effects and biomolecular behavior. Recent research highlights include studies on mycobacterial iron uptake mechanisms and the structural dynamics of pro-apoptotic peptides. Dr. Galazzo’s publications reflect a strong emphasis on interdisciplinary approaches, integrating spectroscopy, computational modeling, and structural biology. Her contributions have advanced methodologies for distance measurements in biomolecules and provided insights into fundamental biological processes such as phase separation and membrane-mediated transport. She is actively engaged in promoting sustainable education through initiatives like the EquipSent project, aiming to enhance global access to scientific resources.
Professor Timothy Schmidt is the Head of the School of Chemistry at the University of New South Wales (UNSW). He holds a BSc (Hons 1M) from the University of Sydney (1997) and a PhD in femtosecond spectroscopy from the University of Cambridge (2002). His research focuses on molecular spectroscopy, astrochemistry, and quantum chemistry, with notable contributions to singlet fission, triplet-triplet annihilation, and exciton science. He is a Chief Investigator in the ARC Centre of Excellence in Exciton Science and has received prestigious awards such as the Coblentz Award (2010) and the RACI Physical Chemistry Medal (2021). His work spans solar energy conversion, interstellar chemistry, and advanced materials. Key grants include the $31.9M ARC Centre of Excellence in Exciton Science (2017-23) and a $403k Discovery Grant for astrochemical spectroscopy (2019-21). He leads the development of photon upconversion technologies and has pioneered studies on carbon-based molecules in space. His teaching includes courses in physical chemistry and advanced chemistry for first-year students. Prof. Schmidt’s labs are based in the Dalton Building and Science and Engineering Building at UNSW, with a focus on cutting-edge spectroscopic techniques. He actively engages in public science communication, including National Science Week talks. His research bridges fundamental physics and applied chemistry, addressing global challenges in energy and materials science.
Aaron Mendez is an Assistant Professor in the Department of Molecular Biology and Microbiology at Tufts University School of Medicine. His research focuses on understanding how viruses maximize their replicative output through the formation of replication compartments, using Kaposi's sarcoma-associated herpesvirus (KSHV) as a model system. Education: PhD in Chemistry & Chemical Biology from the University of California, San Francisco (2015); BSc in Biochemistry & Molecular Biology from the University of California, Irvine (2009). Research Interests: The lab employs a multidisciplinary approach combining molecular virology, biochemistry, and chemical genetics to uncover molecular mechanisms underlying viral replication compartment formation. Key areas include compartment dynamics, viral machinery organization, and evasion of host immune responses. Recent work highlights studies on SOX exonuclease activity in KSHV and SARS-CoV-2 nsp1 protein function. Publications: Recent articles (2014–2023) explore viral replication mechanisms, ER stress pathways, and protein engineering. Notable contributions include elucidating SOX's role in viral DNA processing and characterizing SARS-CoV-2 nsp1's suppression of host gene expression. Grants & Lab Activities: The lab develops novel tools for studying viral replication compartments, with potential applications in antiviral strategies. Current efforts aim to identify linchpin interactions critical for compartment assembly and function. Labs/Teams: Mendez leads a research group focused on advancing virology through innovative biochemical and genetic methodologies.
Takemasa Kawashima is a Researcher affiliated with the Engelman Lab at the Yale School of Medicine. He holds a PhD in Molecular Biophysics from Université Pierre et Marie Curie (1995). His research focuses on structural biology and protein crystallography, particularly studying bacterial translational machinery components like the EF-Tu.EF-Ts complex. He has contributed to understanding the structural dynamics and functional mechanisms of these complexes through X-ray crystallography. His work bridges molecular biophysics and enzymology, with implications for bacterial protein synthesis mechanisms. Education: PhD from Université Pierre et Marie Curie in Molecular Biophysics (1995) Research interests include protein dynamics, enzymatic interactions, and structural insights into molecular processes critical for bacterial physiology. His studies employ advanced crystallographic techniques to elucidate protein complexes at atomic resolution. Advising: No formal advisees listed. His contributions are primarily through collaborative research in the Engelman Lab, focusing on translational systems biology and structural enzymology. Labs/Teams: Active member of the Engelman Lab, engaged in interdisciplinary projects at the Bass Center (266 Whitney Avenue, Fl 4, Rm 425, New Haven, CT).
Ulrich H.E. Hansmann is a Professor in the Department of Chemistry and Biochemistry at the University of Oklahoma. He holds a Ph.D. from Freie Universität Berlin (1990), followed by postdoctoral research at Florida State University and ETH Zürich. His research focuses on computational biophysical chemistry, specifically protein folding, aggregation, and enhanced sampling techniques. His lab develops algorithms and software, such as the SMMP package, to study biomolecular processes relevant to diseases like Alzheimer’s and cancer. Recent work includes investigating the role of microbial infections in amyloidogenesis and SARS-CoV-2 interactions with proteins. He leads the Hansmann Group, which collaborates on projects involving protein-ligand binding and membrane interactions. Education: M.A. (1983), Diplom (1985), Ph.D. (1990) from Freie Universität Berlin. Research Keywords: Protein folding, aggregation, enhanced sampling, amyloidosis, computational modeling. His research explores mechanisms of protein misfolding and aggregation, with applications in drug design and disease pathology. Collaborations include studies on viral proteins’ effects on amyloid formation and antibiotic peptide stability. The SMMP software, developed by his group, enables efficient simulations of large biomolecules.
Mingjiang Zhong is an Associate Professor in the Department of Chemical & Environmental Engineering at Yale University, with additional appointments in Materials Science and Chemistry. His research is centered on the development of advanced synthetic methodologies for functional organic materials and organic-inorganic hybrid systems. Education: B.S., Peking University Ph.D., Carnegie Mellon University His research interests lie at the intersection of polymer chemistry, materials science, and sustainability. He focuses on polymer-derived carbon materials and hierarchical nanostructures for applications in energy conversion, catalysis, and environmental technologies. His group combines sophisticated molecular design with advanced analytical techniques to probe and control complex soft matter behaviors . An analysis of his 15 most recent publications reveals a strong and consistent research trajectory in controlled radical polymerization , particularly in developing novel methods for branching and stereocontrol . His work frequently involves block copolymer self-assembly to create functional nanocomposites and membranes, with a growing emphasis on applications in water treatment (e.g., anti-scaling polymers, desalination membranes) and energy (e.g., electrocatalysts, ion conductors). Scientific Awards and Honors: Camille Dreyfus Teacher-Scholar Award (2022) Wiley Journal of Polymer Science Early Career Investigator (2021) 3M Non-Tenured Faculty Award (2020) National Science Foundation CAREER Award (2019) ACS PMSE Young Investigator (2019) ACS Petroleum Research Fund Doctoral New Investigator (2017) Dr. Zhong leads an active research group, mentoring numerous graduate students and postdoctoral scholars, as evidenced by frequent lab news celebrating student achievements such as passing qualifying exams and successful PhD defenses. His group has secured significant recognition, indicating strong support for research grants. The lab is equipped with state-of-the-art instrumentation for polymer synthesis and characterization, including GPC, GC, and preparative chromatography systems.
W. Steven Ward is a Professor and Director of the Institute for Biogenesis Research (IBR) at the John A. Burns School of Medicine, University of Hawaii. He holds dual affiliations with the Department of Anatomy, Biochemistry and Physiology and the Department of Obstetrics, Gynecology & Women's Health . Education: B.S. in Chemistry, American University of Beirut M.S. in Biochemistry, American University of Beirut Ph.D. in Biochemistry, Vanderbilt University (1985) Research Interests Dr. Ward's work focuses on chromatin structure during spermiogenesis and embryogenesis, particularly the organization of DNA in sperm cells. His lab developed a widely accepted model of sperm chromatin structure based on loop domains, which are critical for paternal DNA replication in embryos. Additional research explores ORC4 protein's role in chromatin expulsion during meiosis and erythrocyte maturation, alongside Exoc5's importance in folliculogenesis. Current projects span three areas: sperm chromatin structure, early embryonic DNA replication, and folliculogenesis biology. Publication Trends His 15 most recent articles (2023–1993) emphasize reproductive biology, developmental genetics, and molecular mechanisms of chromatin organization. Key themes include sperm DNA fragmentation, interspecies comparisons (hamster/mouse models), and the functional implications of chromatin expulsion in oocytes and red blood cells. Collaborative clinical research with urologists and geneticists is evident, particularly in studies linking chromatin structure to fertility outcomes. Grants & Leadership Dr. Ward has maintained continuous NIH funding since 1991 and led a $16M COBRE grant (2009–2025) to develop research capacity at the IBR. As Chief of the Obstetrics and Gynecology Division of Research (2014–), he bridges clinical and basic science, notably through studies on post-vasectomy DNA fragmentation and its developmental impacts. Labs & Teams As IBR director, he leads a multidisciplinary team investigating reproductive biogenesis, including spermatogenesis, oogenesis, and embryonic chromatin dynamics. The lab employs molecular, genetic, and clinical research approaches, often in collaboration with urology and obstetrics departments.
